Evaluation of tibolone effect on arterial resistance in postmenopausal women

Climacteric

Volumn 6, Issue 2, 2003, Pages 151-158

  Grinbaum, M L ^a,b   Ferreira, J A D S ^a   Fernandes, C E ^a   De Azevedo, L H ^a  

^a Medical Sciences School   (Brazil)

^b NONE   (Brazil)

Author keywords

Hormone replacement therapy; Menopause; Pulsatility index; Tibolone; Vascular resistance

Indexed keywords

TIBOLONE;

ADULT; ARTERY RESISTANCE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; COMMON CAROTID ARTERY; DOPPLER FLOWMETRY; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; POPLITEAL ARTERY; POSTMENOPAUSE; PRIORITY JOURNAL; PULSATILE FLOW; RADIAL ARTERY; SUBSTITUTION THERAPY; VASCULAR RESISTANCE;

EID: 0038808600     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.6.2.151.158     Document Type: Article

References (32)

1. Lobo RA. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol 1990;75(Suppl 4):18S-25S, discussion 31S-5S
2. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-62
3. Sullivan JM. Atherosclerosis and estrogen replacement therapy. Int J Fertil Menopausal Stud 1994;(Suppl 1):28-35
4. Coats A. Blood pressure and hypertension. In Stevenson J, ed. Hormone Replacement Therapy and the Cardiovascular System. Abingdon, UK: The Medicine Group, 1994:24-6
5. Jackson S, Vyas S. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index. Br J Obstet Gynaecol 1998;105:408-12
6. Ross LA, Alder EM. Tibolone and climacteric symptoms. Maturitas 1995;21:127-36
7. Riggs BL. Tibolone as an alternative to estrogen for the prevention of postmenopausal osteoporosis in selected postmenopausal women [Editorial; Comment] [published erratum appears in J Clin Endocrinol Metab 1997;82:181]. J Clin Endocrinol Metab 1996;81:2417-18
8. Rymer JM. The effects of tibolone. Gynecol Endocrinol 1998;12:213-20
9. Speroff L. Postmenopausal hormone therapy and breast cancer. Obstet Gynecol 1996;87(Suppl 2):44S-54S
10. Rymer J, Crook D, Sidhu M, Chapman M, Stevenson JC. Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women. Acta Endocrinol (Copenh) 1993;128:259-62
11. Palacios S. Tibolone: what does tissue specific activity mean? Maturitas 2001;37:159-65
12. Kloosterboer HJ. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76:231-8
13. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11
14. Meyer WJ, Jaffe R. Basic principles of Doppler ultrasonography. In Bolger EM, ed. Color Doppler Imaging in Obstetrics and Gynecology. New York: McGraw-Hill, 1992:1-16
15. Pearson JD. Vasoactive substances. In Stevenson J, ed. Hormone Replacement Therapy and the Cardiovascular System. Abingdon, UK: The Medicine Group, 1994:27-9
16. Beale CM, Collins P. The menopause and the cardiovascular system. Baillière's Clin Obstet Gynaecol 1996;10:483-513
17. Cerri GG, Molnar RJ, Vezozzo DCT. Princípios básicos e instrumentação. In Cerri GG, ed. Doppler. São Paulo: Sarvier; 1996:3-16
18. Kuhl H. Cardiovascular disease and estrogen replacement therapy - epidemiological data. In Rippert TH, Mueck OA, Ginsburg J, eds. Sex Steroids and the Cardiovascular System. Carnforth, UK: Parthenon Publishing, 1996:97-109
19. Cacciatore B, Paakkari I, Toivonen J, Tikkanen MJ, Ylikorkala O. Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow. Obstet Gynecol 1998;92:563-8
20. de Ziegler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone. Fertil Steril 1991;55:775-9
21. Penotti M, Farina M, Castiglioni E, et al. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study. Am J Obstet Gynecol 1996;175:606-11
22. Lau TK, Wan D, Yim SF, Sanderson JE, Haines CJ. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women. Fertil Steril 1998;70:284-8
23. Feher MD, Cox A, Levy A, Mayne P, Lant AF. Short term blood pressure and metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes. Br J Obstet Gynaecol 1996;103:281-3
24. Zandberg P, Peters JL, Demacker PN, Smit MJ, de Reeder EG, Meuleman DG. Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits. Arterioscler Thromb Vasc Biol 1998;18:1844-54
25. Lloyd G, McGing E, Cooper A, et al. A randomised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women. J Hum Hypertens 2000;14:99-104
26. Farish E, Barnes JF, Fletcher CD, Ekevall K, Calder A, Hart DM. Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen. Menopause 1999;6:98-104
27. Bourne T, Hillard TC, Whitehead MI, Crook D, Campbell S. Oestrogens, arterial status, and postmenopausal women. Lancet 1990;335:1470-1
28. Penotti M, Nencioni T, Gabrielli L, Farina M, Castiglioni E, Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am J Obstet Gynecol 1993;169:1226-32
29. Hillard TC, Bourne TH, Whitehead MI, Crayford TB, Collins WP, Campbell S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992;58:959-63
30. Darj E, Bakos O, Naessen T, Persson I. Ultra-sonographic blood flow measurement in the carotid arteries in postmenopausal women. Gynecol Obstet Invest 1997;47:20-5
31. Lau TK, Chung TK, Haines CJ. A preliminary study on the effect of hormone replacement therapy on peripheral flow velocity in postmenopausal women. Maturitas 1997;26:53-6
32. Hardiman P, Nihoyannopoulos P, Kicovic P, Ginsburg J. Cardiovascular effects of Org OD 14 - a new steroidal therapy for climacteric symptoms. Maturitas 1991;13:235-42